Is the BioNTech-Pfizer COVID-19 vaccination effective in elderly populations? Results from population data from Bavaria, Germany
Delphina Gomes, Andreas Beyerlein, Katharina Katz, Gabriele Hoelscher, Uta Nennstiel, Bernhard Liebl, Klaus Überla, Rüdiger von Kries
doi: https://doi.org/10.1101/2021.08.19.21262266
Delphina Gomes
1Institute of Social Pediatrics and Adolescent Medicine, Division of Pediatric Epidemiology, Ludwig-Maximilians-University, Munich, Germany
Andreas Beyerlein
1Institute of Social Pediatrics and Adolescent Medicine, Division of Pediatric Epidemiology, Ludwig-Maximilians-University, Munich, Germany
Katharina Katz
2Bavarian Health and Food Safety Authority, Oberschleissheim, Germany
Gabriele Hoelscher
2Bavarian Health and Food Safety Authority, Oberschleissheim, Germany
Uta Nennstiel
2Bavarian Health and Food Safety Authority, Oberschleissheim, Germany
Bernhard Liebl
2Bavarian Health and Food Safety Authority, Oberschleissheim, Germany
Klaus Überla
3Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
Rüdiger von Kries
1Institute of Social Pediatrics and Adolescent Medicine, Division of Pediatric Epidemiology, Ludwig-Maximilians-University, Munich, Germany
Data Availability
Data cannot be shared publicly because participants did not explicitly consent to the sharing of their data as per European Unions General Data Protection Regulation and the corresponding German privacy laws. Data are available through the Research Ethics Board of the Ludwig-Maximilians-Universitaet Muenchen, Munich/Germany for researchers who meet the criteria for access to confidential data.
Posted August 21, 2021.
Is the BioNTech-Pfizer COVID-19 vaccination effective in elderly populations? Results from population data from Bavaria, Germany
Delphina Gomes, Andreas Beyerlein, Katharina Katz, Gabriele Hoelscher, Uta Nennstiel, Bernhard Liebl, Klaus Überla, Rüdiger von Kries
medRxiv 2021.08.19.21262266; doi: https://doi.org/10.1101/2021.08.19.21262266
Is the BioNTech-Pfizer COVID-19 vaccination effective in elderly populations? Results from population data from Bavaria, Germany
Delphina Gomes, Andreas Beyerlein, Katharina Katz, Gabriele Hoelscher, Uta Nennstiel, Bernhard Liebl, Klaus Überla, Rüdiger von Kries
medRxiv 2021.08.19.21262266; doi: https://doi.org/10.1101/2021.08.19.21262266
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2878)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12610)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4480)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (909)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4240)
- Nursing (228)
- Nutrition (621)
- Oncology (2224)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6827)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (60)
- Transplantation (204)
- Urology (175)